Ikarian Capital, LLC Relay Therapeutics, Inc. Transaction History
Ikarian Capital, LLC
- $754 Million
- Q1 2024
A detailed history of Ikarian Capital, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 80,000 shares of RLAY stock, worth $714,400. This represents 0.18% of its overall portfolio holdings.
Number of Shares
80,000Holding current value
$714,400% of portfolio
0.18%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding RLAY
# of Institutions
190Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$249 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$106 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$87.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$66.3 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$61.4 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $1.07B
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...